Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Electroconvulsive therapy and subdural hemorrhage.

C Wijeratne1, S Shome

  • 1Division of Psychiatry, St. George Hospital, Kogarah, New South Wales, Australia.

The Journal of ECT
|December 30, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-coding RNA in raw and commercially processed milk and putative targets related to growth and immune-response.

BMC genomics·2021
Same author

Doctors' reporting of mental health stigma and barriers to help-seeking.

Occupational medicine (Oxford, England)·2021
Same author

Influence of socio-economic status and television watching on childhood obesity in Kolkata.

Homo : internationale Zeitschrift fur die vergleichende Forschung am Menschen·2017
Same author

Late-onset bipolar disorder: preliminary results from Sydney.

Acta neuropsychiatrica·2016
Same author

Electrographic Response of the Heart to Myocardial Ischemia.

Computers in cardiology·2016
Same author

The psychology of self-immolation in India.

Indian journal of psychiatry·2011
Same journal

Successful Use of Electroconvulsive Therapy in Treatment-Resistant Catatonia With Comorbid Parkinson Disease and Neuroborreliosis: A Case Report.

The journal of ECT·2026
Same journal

Electroconvulsive Therapy in Movement Disorders: A Systematic Review.

The journal of ECT·2026
Same journal

Presyncope During Repetitive Transcranial Magnetic Stimulation With Treatment Continuation.

The journal of ECT·2026
Same journal

Comparison of Electroconvulsive Therapy Seizure Outcomes When Using Methohexital Versus Propofol: A Brief Retrospective Report.

The journal of ECT·2026
Same journal

Changes in the Use of Repetitive Transcranial Magnetic Stimulation Therapy Between 2016 and 2022 in Northern Finland.

The journal of ECT·2026
Same journal

Evaluation of Cardiac Adverse Effects After Transition From Bitemporal to Bifrontal ECT.

The journal of ECT·2026
See all related articles

Electroconvulsive therapy (ECT) can be safely administered to patients with subdural hemorrhage (SDH) when specific precautions are taken. Careful monitoring and modified treatment protocols are essential for managing severe depressive illness in these cases.

Area of Science:

  • Neurology
  • Psychiatry

Background:

  • Severe depressive illness requires effective treatment, but comorbidities like subdural hemorrhage (SDH) pose unique challenges.
  • Electroconvulsive therapy (ECT) is a potent treatment for severe depression, yet its safety in patients with intracranial conditions is a concern.

Observation:

  • Two patients with severe depressive illness and concurrent or post-neurosurgical subdural hemorrhage (SDH) underwent electroconvulsive therapy (ECT).
  • Neither patient experienced an extension of the SDH or other intracranial complications during or after ECT.

Findings:

  • Electroconvulsive therapy (ECT) was safely performed in a patient with subdural hemorrhage (SDH) following neurosurgery and in another with concurrent SDH without mass effect.
  • Despite one patient's death from unrelated causes one month post-ECT, no adverse intracranial events were attributed to the therapy in either case.

Related Experiment Videos

Implications:

  • ECT can be considered a safe treatment option for severe depressive illness in patients with uncomplicated subdural hemorrhage (SDH) or after surgical drainage.
  • Clinicians must exercise caution, collaborate with neurosurgical teams, monitor neuroimaging, and employ modified ECT protocols (dose titration, unilateral placement) to minimize risks.